

Carol D. Miller
U.S. Representative (R) for West Virginia, 76 years old.
- B.S. Columbia College (1972)
MILLER, Carol Devine, (daughter of [Samuel Leeper Devine](https://bioguide.congress.gov/search/bio/D000279) ), a Representative from West Virginia; born in Columbus, Franklin County, Ohio, November 4, 1950; graduated from Bexley High School, Bexley, Ohio, 1968; B.S., Columbia College, Columbia, S.C., 1972; member of the West Virginia house of delegates, 2007-2019; elected as a Republican to the One Hundred Sixteenth and to the three succeeding Congresses (January 3, 2019-present).
Source: U.S. Congress Bioguide / public-record corporate filings.
Track record by window
Disclosed trades · 63
All filings →| Filed | Trade date | Type | Stock | Smart move? | Size |
|---|---|---|---|---|---|
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | H HSYStock (HSY) ⚑ Consumer Defensive · Health | Flat·+0.0% −1.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↓sold | Pfizer, Inc. Common Stock (PFE) ⚑ Pharmaceutical · Committee on Ways and Means | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | PepsiCo, Inc. - Common Stock (PEP) ⚑ Consumer Defensive · Health | Flat·-0.2% −1.3% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | Common Stock (LMT) | Good buy·+$897+11.2% −43.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | Stock (ITW) ⚑ Industrials · Trade | Bad buy·−$448-5.6% −37.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | Common Stock (HON) ⚑ Industrials · Trade | Good buy·+$1.2K+15.4% −16.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | (GILD) ⚑ Pharmaceutical · Committee on Ways and Means | Good buy·+$1.2K+15.3% +14.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | C CMEStock (CME) ⚑ Banking · Committee on Ways and Means | Bad buy·−$407-5.1% −13.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | A AWKInc. Common Stock (AWK) | Bad buy·−$1.3K-16.0% −31.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↑bought | A AFLAFLAC Incorporated Common Stock (AFL) ⚑ Financial Services · Committee on Ways and Means | Good buy·+$589+7.4% −0.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↓sold | Stock (UPS) Matt Miller Investment Management Account | Flat·+0.0% +31.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↓sold | U.S. Bancorp Common Stock (USB) ⚑ Banking · Committee on Ways and Means | Flat·+0.0% +8.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↓sold | Target Corporation Common Stock (TGT) ⚑ Consumer Cyclical · Trade | Flat·+0.0% +20.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 11, 2025 | Mar 10, 2025 32 days to disclose | ↓sold | D DGXCommon Stock (DGX) ⚑ Healthcare · Committee on Ways and Means | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Sep 13, 2024 | Aug 12, 2024 32 days to disclose | ↓sold | W WBDA Common Stock (WBD) | Missed gain·−$24.3K-303.4% −269.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | C COKECommon Stock (COKE) | Missed gain·−$8.6K-107.0% −69.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | AT&T Inc. (T) | Missed gain·−$4.3K-53.1% −15.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | AT&T Inc. (T) | Missed gain·−$4.3K-53.1% −15.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | Common Stock (CMCSA) | Smart sell·+$2K+24.7% +62.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | C COKECommon Stock (COKE) | Missed gain·−$8.6K-107.0% −69.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | Common Stock (CMCSA) | Smart sell·+$8K+24.7% +62.7% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | M MCKStock (MCK) ⚑ Healthcare · Committee on Ways and Means | Missed gain·−$17K-52.3% −14.3% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | M MCKStock (MCK) ⚑ Healthcare · Committee on Ways and Means | Missed gain·−$17K-52.3% −14.3% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Jun 5, 2024 | May 8, 2024 28 days to disclose | ↓sold | Yum! Brands, Inc. (YUM) ⚑ Consumer Cyclical · Trade | Missed gain·−$1.4K-17.0% +21.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 7, 2023 | Nov 30, 2023 7 days to disclose | ↑bought | I IGSBCorporate Bond ETF (IGSB) | Good buy·+$317+4.0% −52.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 7, 2023 | Nov 28, 2023 9 days to disclose | ↓sold | C CORP(CORP) | Missed gain·−$318-4.0% +53.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Nov 9, 2023 | Oct 6, 2023 34 days to disclose | ↑bought | E EMXCChina ETF (EMXC) | Good buy·+$26.7K+82.1% +15.9% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Nov 9, 2023 | Oct 6, 2023 34 days to disclose | ↑bought | E EMXCChina ETF (EMXC) | Good buy·+$61.5K+82.1% +15.9% vs S&P 500 | $50K-$100K $50,001 - $100,000 5.6% of book |
| Apr 17, 2023 | Mar 3, 2023 45 days to disclose | ↓sold | Cummins Inc. (CMI) ⚑ Industrials · Trade | Missed gain·−$12.5K-156.0% −79.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Apr 17, 2023 | Mar 3, 2023 45 days to disclose | ↓sold | P PARAParamount Global - Class B (PARA) | price pending | $1K-$15K $1,001 - $15,000 0.6% of book |
| Jan 4, 2023 | Dec 22, 2022 13 days to disclose | ↑bought | S SHYiShares 1-3 Year Treasury Bond ETF (SHY) | Good buy·+$2.6K+1.5% −86.0% vs S&P 500 | $100K-$250K $100,001 - $250,000 13.1% of book |
| Dec 13, 2022 | Nov 14, 2022 29 days to disclose | ↑bought | D DGXQuest Diagnostics Incorporated (DGX) ⚑ Healthcare · Committee on Ways and Means | Good buy·+$2.4K+30.5% −50.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 13, 2022 | Nov 11, 2022 32 days to disclose | ↑bought | Target Corporation (TGT) ⚑ Consumer Cyclical · Trade | Bad buy·−$8.3K-25.4% −104.6% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Dec 13, 2022 | Nov 11, 2022 32 days to disclose | ↑bought | Texas Instruments Incorporated (TXN) ⚑ Technology · Trade | Good buy·+$17.7K+54.4% −24.7% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Dec 13, 2022 | Nov 11, 2022 32 days to disclose | ↑bought | S SCHPSchwab U.S. TIPs ETF (SCHP) | Good buy·+$201+2.5% −76.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 13, 2022 | Nov 2, 2022 41 days to disclose | ↑bought | V VYMVanguard High Dividend Yield ETF (VYM) | Good buy·+$15.4K+47.3% −43.1% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Dec 13, 2022 | Nov 2, 2022 41 days to disclose | ↑bought | F FHYSHigh Yield ETF (FHYS) | Good buy·+$467+5.8% −84.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 13, 2022 | Nov 2, 2022 41 days to disclose | ↑bought | F FDEVMultifactor ETF (FDEV) | Good buy·+$5.2K+64.7% −25.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 13, 2022 | Nov 2, 2022 41 days to disclose | ↑bought | E EFAiShares MSCI EAFE ETF (EFA) | Good buy·+$5.8K+72.8% −17.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 13, 2022 | Nov 2, 2022 41 days to disclose | ↑bought | C CORP(CORP) | Good buy·+$608+7.6% −82.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Dec 13, 2022 | Nov 2, 2022 41 days to disclose | ↑bought | V VUGVanguard Growth ETF (VUG) | Good buy·+$30.4K+135.0% +44.6% vs S&P 500 | $15K-$30K $15,001 1.7% of book |
| Dec 13, 2022 | Nov 1, 2022 42 days to disclose | ↑bought | I IJRiShares Core S&P Small-Cap ETF (IJR) | Good buy·+$3.1K+38.6% −47.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.6% of book |
| Sep 2, 2022 | Aug 8, 2022 25 days to disclose | ↑bought | Target Corporation (TGT) ⚑ Consumer Cyclical · Trade | Bad buy·−$7.3K-22.6% −95.5% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Aug 8, 2022 25 days to disclose | ↓sold | Emerson Electric Company (EMR) ⚑ Industrials · Trade | Missed gain·−$18.5K-57.0% +15.9% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Nov 10, 2021 296 days to disclose · 251 past 45-day window | ↓sold | Bristol-Myers Squibb Company (BMY) ⚑ Pharmaceutical · Committee on Ways and Means | Smart sell·+$372+1.1% +55.1% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Nov 10, 2021 296 days to disclose · 251 past 45-day window | ↓sold | BlackRock, Inc. (BLK) ⚑ Banking · Committee on Ways and Means | Missed gain·−$2K-8.9% +45.1% vs S&P 500 | $15K-$30K $15,001 1.7% of book |
| Sep 2, 2022 | Nov 10, 2021 296 days to disclose · 251 past 45-day window | ↓sold | Johnson & Johnson (JNJ) ⚑ Pharmaceutical · Committee on Ways and Means | Missed gain·−$8.7K-38.5% +15.5% vs S&P 500 | $15K-$30K $15,001 1.7% of book |
| Sep 2, 2022 | Nov 10, 2021 296 days to disclose · 251 past 45-day window | ↓sold | L3Harris Technologies, Inc. (LHX) | Missed gain·−$13.7K-42.1% +11.9% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↓sold | Gilead Sciences, Inc. (GILD) ⚑ Pharmaceutical · Committee on Ways and Means | Missed gain·−$19.4K-86.1% −23.4% vs S&P 500 | $15K-$30K $15,001 1.7% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↑bought | General Dynamics Corporation (GD) | Good buy·+$19.6K+60.2% −2.5% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↓sold | D DDominion Energy, Inc. (D) | Smart sell·+$5.6K+17.4% +80.1% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↑bought | Amgen Inc. (AMGN) ⚑ Pharmaceutical · Committee on Ways and Means | Good buy·+$13.3K+41.1% −21.6% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↑bought | Texas Instruments Incorporated (TXN) ⚑ Technology · Trade | Good buy·+$15.7K+48.3% −14.4% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↑bought | D DGXQuest Diagnostics Incorporated (DGX) ⚑ Healthcare · Committee on Ways and Means | Good buy·+$13.1K+40.2% −22.5% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↑bought | Procter & Gamble Company (PG) ⚑ Consumer Defensive · Health | Good buy·+$2.2K+6.8% −55.9% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↓sold | Stock (MRK) ⚑ Pharmaceutical · Committee on Ways and Means | Missed gain·−$13.9K-42.9% +19.8% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Jul 28, 2021 401 days to disclose · 356 past 45-day window | ↓sold | H HRLHormel Foods Corporation (HRL) ⚑ Consumer Defensive · Health | Smart sell·+$17.6K+54.1% +116.8% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Mar 4, 2021 547 days to disclose · 502 past 45-day window | ↑bought | Abbott Laboratories (ABT) ⚑ Healthcare · Committee on Ways and Means | price pending | $15K-$50K $15,001 - $50,000 2.4% of book |
| Sep 2, 2022 | Mar 4, 2021 547 days to disclose · 502 past 45-day window | ↑bought | V VTRSViatris Inc. (VTRS) ⚑ Healthcare · Committee on Ways and Means | price pending | $1K-$15K $1,001 - $15,000 0.6% of book |
| Sep 2, 2022 | Mar 4, 2021 547 days to disclose · 502 past 45-day window | ↑bought | I IRMIron Mountain Incorporated (IRM) ⚑ Real Estate · Committee on Ways and Means | price pending | $1K-$15K $1,001 - $15,000 0.6% of book |
| Sep 2, 2022 | Mar 4, 2021 547 days to disclose · 502 past 45-day window | ↑bought | Clorox Company (CLX) ⚑ Consumer Defensive · Health | price pending | $1K-$15K $1,001 - $15,000 0.6% of book |
| Sep 2, 2022 | Mar 4, 2021 547 days to disclose · 502 past 45-day window | ↑bought | Cisco Systems, Inc. (CSCO) ⚑ Technology · Trade | price pending | $15K-$50K $15,001 - $50,000 2.4% of book |
| Jan 14, 2022 | Dec 14, 2021 31 days to disclose | ↑bought | A APDAir Products and Chemicals, Inc. (APD) | Good buy·+$388+1.2% −52.9% vs S&P 500 | $15K-$50K $15,001 - $50,000 2.4% of book |
Their record vs the S&P 500
57 priced trades compared to a same-direction S&P 500 benchmark.
Oversight committees · 3
Click any committee to see what it actually does, which sectors it regulates, and why each sector tag was attached. Sources cited.
Recent legislative activity · 40 bills
20 sponsored, 20 cosponsored in the 119th Congress. Color-coded by sector — yellow chips mark bills that overlap a sector this politician has actually traded in.
- Expressing support for the designation of May 17, 2026, as "Necrotizing Enterocolitis Awareness Day".Referred to the House Committee on Energy and Commerce.
- To amend the Internal Revenue Code of 1986 to enhance the qualified business income deduction for domestic manufacturers, and for other purposes.Referred to the House Committee on Ways and Means.
- Workforce Reentry ActReferred to the House Committee on Education and Workforce.
- Love Lives On Act of 2025Forwarded by Subcommittee to Full Committee by Voice Vote.
- Rural Residency Planning and Development Act of 2025Referred to the House Committee on Energy and Commerce.
- sponsorHR 70702026-04-27Financial ServicesReal EstateHealthcarePharmaceuticalEnergyBasic MaterialsBankingTo amend the Internal Revenue Code of 1986 to extend the credit period for the production of refined coal, and for other purposes.Referred to the House Committee on Ways and Means.
- Iran Human Rights, Internet Freedom, and Accountability Act of 2026Referred to the Committee on Foreign Affairs, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Find It Early ActReferred to the Subcommittee on Health.
- United States-Israel FUTURES Act of 2026Referred to the Committee on Armed Services, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- American Franchise ActReferred to the House Committee on Education and Workforce.
- To amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination.Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Small Business Tax Cut ActReferred to the House Committee on Ways and Means.
- Recognizing April as Cancer Prevention and Early Detection Month.Referred to the House Committee on Energy and Commerce.
- Rural Hospital Flexibility Act of 2025Referred to the House Committee on Ways and Means.
- Improve and Enhance the Work Opportunity Tax Credit ActReferred to the House Committee on Ways and Means.
- Provider Reimbursement Stability Act of 2026Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 44 - 0.
- Expressing support for the designation of April 2026 as "Second Chance Month".Referred to the House Committee on the Judiciary.
- Expressing support for tax policies that support working families.Motion to reconsider laid on the table Agreed to without objection.
- Manifest Modernization Act of 2025Referred to the House Committee on Ways and Means.
- Buying American Cotton Act of 2026Referred to the House Committee on Ways and Means.